| scholarly article | Q13442814 |
| P2093 | author name string | Ting-Ting Wu | |
| Shui-Hong Zhou | |||
| P2860 | cites work | Ubiquitin-dependent intramembrane rhomboid protease promotes ERAD of membrane proteins | Q24293182 |
| A novel member of the Rhomboid family, RHBDD1, regulates BIK-mediated apoptosis | Q24309275 | ||
| Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells | Q24318727 | ||
| A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma | Q24322614 | ||
| Phosphorylation and cleavage of presenilin-associated rhomboid-like protein (PARL) promotes changes in mitochondrial morphology | Q24675079 | ||
| The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy | Q24801373 | ||
| Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? | Q26999332 | ||
| Crystal structure of the human glucose transporter GLUT1 | Q27690274 | ||
| Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival | Q27851502 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
| Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 | ||
| On the Origin of Cancer Cells | Q27861025 | ||
| Post-transcriptional gene silencing by double-stranded RNA | Q28205087 | ||
| Radiotherapy enhancement with gold nanoparticles | Q28288052 | ||
| Smoking and drinking in relation to oral and pharyngeal cancer | Q28297089 | ||
| Case-control study of human papillomavirus and oropharyngeal cancer | Q28301695 | ||
| RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals | Q29547713 | ||
| An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells | Q29547714 | ||
| Nanocarriers as an emerging platform for cancer therapy | Q29616699 | ||
| Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck | Q29619277 | ||
| Current advances in research and clinical applications of PLGA-based nanotechnology | Q30482916 | ||
| Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. | Q30486828 | ||
| Poly-L-arginine and Dextran Sulfate-Based Nanocomplex for Epidermal Growth Factor Receptor (EGFR) siRNA Delivery: Its Application for Head and Neck Cancer Treatment | Q31043482 | ||
| Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles | Q33224381 | ||
| Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies | Q33280687 | ||
| Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival | Q33515519 | ||
| Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma | Q33713871 | ||
| CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules. | Q33817704 | ||
| Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4 | Q33898862 | ||
| Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy | Q33972586 | ||
| Effective Drug Delivery, In Vitro and In Vivo, by Carbon-Based Nanovectors Noncovalently Loaded with Unmodified Paclitaxel | Q34111578 | ||
| Pegnology: a review of PEG-ylated systems | Q34113495 | ||
| Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE | Q34247194 | ||
| Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs | Q34298362 | ||
| Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty | Q38561887 | ||
| Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation | Q39023305 | ||
| Lentiviral Vector Mediated Delivery of RHBDD1 shRNA down Regulated the Proliferation of Human Glioblastoma Cells | Q39120825 | ||
| RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy | Q39146064 | ||
| Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma. | Q39218915 | ||
| Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells | Q39243572 | ||
| Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy | Q39325848 | ||
| Synthesis and characterization of amphiphilic chitosan derivatives as a nano-carrier for paclitaxel delivery | Q39423186 | ||
| Gold nanorod-sphingosine kinase siRNA nanocomplexes: a novel therapeutic tool for potent radiosensitization of head and neck cancer | Q39429999 | ||
| Cationic drug-derived nanoparticles for multifunctional delivery of anticancer siRNA. | Q39470280 | ||
| Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy | Q39481822 | ||
| Transferrin receptors in human tissues: their distribution and possible clinical relevance | Q39510082 | ||
| Oligodeoxynucleotides as inhibitors of gene expression: a review. | Q39636846 | ||
| Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug | Q39640656 | ||
| Antisense treatment of IGF-IR enhances chemosensitivity in squamous cell carcinomas of the head and neck | Q39706443 | ||
| Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway | Q39749612 | ||
| Inhibition of the EGFR with nanoparticles encapsulating antisense oligonucleotides of the EGFR enhances radiosensitivity in SCCVII cells | Q39817106 | ||
| Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1. | Q39851737 | ||
| GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis | Q39872802 | ||
| Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin | Q39897646 | ||
| Construction and identification of an antisense glucose transporter-1 plasmid | Q39933194 | ||
| Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neck. | Q39979580 | ||
| Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck | Q40048557 | ||
| Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells | Q40057512 | ||
| Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes | Q40112405 | ||
| Effects of MnSOD-plasmid liposome gene therapy on antioxidant levels in irradiated murine oral cavity orthotopic tumors | Q40168136 | ||
| Effect of EGFR antagonists gefitinib (Iressa) and C225 (Cetuximab) on MnSOD-plasmid liposome transgene radiosensitization of a murine squamous cell carcinoma cell line. | Q40186736 | ||
| A phase I study of OGX-011, a 2'-methoxyethyl phosphorothioate antisense to clusterin, in combination with docetaxel in patients with advanced cancer | Q40428088 | ||
| Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy. | Q40444331 | ||
| Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell lines | Q40522328 | ||
| Specific inhibition of the rat ligand-gated ion channel P2X3 function via methoxyethoxy-modified phosphorothioated antisense oligonucleotides | Q40793546 | ||
| TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo | Q40906936 | ||
| Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression | Q43134569 | ||
| Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice | Q43149390 | ||
| RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system | Q43192622 | ||
| Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system. | Q43284749 | ||
| Poly(ethylene glycol)-human serum albumin-paclitaxel conjugates: preparation, characterization and pharmacokinetics | Q43725891 | ||
| Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes | Q43938215 | ||
| Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. | Q44260431 | ||
| Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancer | Q44293455 | ||
| Prevention of radiation-induced oral cavity mucositis by plasmid/liposome delivery of the human manganese superoxide dismutase (SOD2) transgene | Q44324277 | ||
| Liposomal nanomedicines | Q37039021 | ||
| HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. | Q37069841 | ||
| Effect of antisense oligodeoxynucleotides glucose transporter-1 on enhancement of radiosensitivity of laryngeal carcinoma | Q37121378 | ||
| Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug | Q37135687 | ||
| Cancer cells survive with survivin | Q37185505 | ||
| A Cell-Targeted Photodynamic Nanomedicine Strategy for Head and Neck Cancers | Q37190425 | ||
| Chemotherapy for recurrent and metastatic head and neck cancer | Q37297291 | ||
| Knocking down barriers: advances in siRNA delivery | Q37380671 | ||
| Multimodal treatment for head and neck cancer | Q37383031 | ||
| Rhomboid domain containing 2 (RHBDD2): a novel cancer-related gene over-expressed in breast cancer | Q37419573 | ||
| Small silencing RNAs: state-of-the-art | Q37475724 | ||
| The forthcoming applications of gold nanoparticles in drug and gene delivery systems. | Q37651864 | ||
| Fluorodeoxyglucose uptake in laryngeal carcinoma is associated with the expression of glucose transporter-1 and hypoxia-inducible-factor-1α and the phosphoinositide 3-kinase/protein kinase B pathway | Q37652530 | ||
| Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects | Q37732204 | ||
| Surface plasmon resonance biosensors incorporating gold nanoparticles. | Q37993520 | ||
| Leaky tumor vessels: consequences for tumor stroma generation and for solid tumor therapy. | Q37999837 | ||
| Nanotechnology applied to overcome tumor drug resistance | Q38018774 | ||
| Photodynamic therapy: oncologic horizons | Q38170385 | ||
| Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. | Q38177110 | ||
| Clinical PD/PDT in North America: An historical review | Q38232431 | ||
| Novel aspects of encapsulation and delivery using polymersomes | Q38259201 | ||
| Amphiphilic poly(amino acid) based micelles applied to drug delivery: the in vitro and in vivo challenges and the corresponding potential strategies. | Q38286971 | ||
| Functional comparison of single- and double-stranded siRNAs in mammalian cells | Q38343421 | ||
| Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck. | Q38348642 | ||
| Inhibition of ataxia-telangiectasia mutated by antisense oligonucleotide nanoparticles induces radiosensitization of head and neck squamous-cell carcinoma in mice | Q38354185 | ||
| Rhomboid domain containing 1 inhibits cell apoptosis by upregulating AP‐1 activity and its downstream target Bcl‐3 | Q44441240 | ||
| HER-2-targeted antisense oligonucleotide results in sensitization of head and neck cancer cells to chemotherapeutic agents | Q44748712 | ||
| Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database | Q44849577 | ||
| Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles | Q44920078 | ||
| Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis. | Q45059966 | ||
| Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures | Q45087628 | ||
| Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma | Q45213619 | ||
| A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck | Q45236091 | ||
| Epidermal growth factor receptor--mediated stat3 signaling blocks apoptosis in head and neck cancer | Q45867493 | ||
| Intratracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation | Q45868906 | ||
| Inhibition of Human Squamous Cell Carcinoma Growth In Vivo by Epidermal Growth Factor Receptor Antisense RNA Transcribed From the U6 Promoter | Q45888433 | ||
| The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. | Q45977543 | ||
| Hypothesis: using the Warburg effect against cancer by reducing glucose and providing lactate | Q46098984 | ||
| GLUT1 protein expression correlates with unfavourable histologic category and high risk in patients with neuroblastic tumours. | Q46180186 | ||
| Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors | Q46653730 | ||
| HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma | Q47288557 | ||
| Defining the drug incorporation properties of PLA-PEG nanoparticles. | Q51403198 | ||
| PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. | Q51475804 | ||
| Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma | Q52581305 | ||
| Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. | Q53008600 | ||
| Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck | Q53058252 | ||
| Role of FDG‐PET as a biological marker for predicting the hypoxic status of tongue cancer | Q53193315 | ||
| Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. | Q53479014 | ||
| Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo | Q53960627 | ||
| Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer | Q54493753 | ||
| [Effect of survivin antisense oligodeoxynucleotide on carcinoma of larynx in vivo and in vitro]. | Q54604866 | ||
| Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium | Q57559757 | ||
| Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits | Q69900353 | ||
| Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis | Q72393641 | ||
| Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation | Q73448001 | ||
| Downmodulation of TGF-α protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells | Q74346536 | ||
| Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications | Q74602420 | ||
| Head and neck cancer | Q77387887 | ||
| Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity | Q79506613 | ||
| Targeted drug delivery via folate receptors | Q80816524 | ||
| In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice | Q81697594 | ||
| Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA | Q82636471 | ||
| A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer | Q84509376 | ||
| Expression of RHBDD1 gene in patients with chronic myeloid leukemia and its clinical significance | Q86364174 | ||
| Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans | Q34345458 | ||
| Characterization of a human rhomboid homolog, p100hRho/RHBDF1, which interacts with TGF-alpha family ligands | Q34427646 | ||
| Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy | Q34428540 | ||
| Heat shock proteins in cancer: chaperones of tumorigenesis | Q34495261 | ||
| Hsp27: novel regulator of intracellular redox state | Q34564355 | ||
| Invited review: Interplay between molecular chaperones and signaling pathways in survival of heat shock | Q34564831 | ||
| Clinical experience of MEK inhibitors in cancer therapy | Q34595700 | ||
| Nanocapsule technology: a review. | Q34799194 | ||
| Protein kinase CK2: structure, regulation and role in cellular decisions of life and death | Q34978734 | ||
| Sphingosine kinase, sphingosine-1-phosphate, and apoptosis | Q35047178 | ||
| Biodegradable nanoparticles for drug and gene delivery to cells and tissue | Q35082117 | ||
| Noncovalent Functionalization of Carbon Nanovectors with an Antibody Enables Targeted Drug Delivery | Q35177908 | ||
| Targeted Dendrimer Chemotherapy in an Animal Model for Head and Neck Squamous Cell Carcinoma | Q35184402 | ||
| Protein kinase CK2 in health and disease: CK2: a key player in cancer biology | Q35270830 | ||
| Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo | Q35676433 | ||
| Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy | Q35749863 | ||
| Folate-targeted chemotherapy | Q35749880 | ||
| Biologically active sphingolipids in cancer pathogenesis and treatment | Q35852313 | ||
| Noncovalent assembly of targeted carbon nanovectors enables synergistic drug and radiation cancer therapy in vivo | Q35856908 | ||
| Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth. | Q35947017 | ||
| Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging | Q35995110 | ||
| Repopulation of cancer cells during therapy: an important cause of treatment failure | Q36167592 | ||
| Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth | Q36186343 | ||
| Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production. | Q36186475 | ||
| Epidermal growth factor receptor directed therapy in head and neck cancer | Q36278199 | ||
| Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors | Q36405679 | ||
| Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck. | Q36437544 | ||
| Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma | Q36475940 | ||
| The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications | Q36488138 | ||
| Programmed drug delivery: nanosystems for tumor targeting | Q36810261 | ||
| Systemic and global toxicities of head and neck treatment | Q36879176 | ||
| Protein kinase CK2--a key suppressor of apoptosis | Q36994133 | ||
| Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine | Q37014465 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| head and neck neoplasms | Q18975915 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 187-200 | |
| P577 | publication date | 2015-01-01 | |
| 2015-01-12 | |||
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | International Journal of Medical Sciences | Q10927439 |
| P1476 | title | Nanoparticle-based targeted therapeutics in head-and-neck cancer | |
| P478 | volume | 12 |
| Q94465887 | Biomimetic Gold Nanoshell-Loaded Macrophage for Photothermal Biomedicine |
| Q60922841 | Complete Disaggregation of MCF-7-derived Breast Tumour Spheroids with Very Low Concentrations of α-Mangostin Loaded in CD44 Thioaptamer-tagged Nanoparticles |
| Q90220710 | Nanomaterial-based blood-brain-barrier (BBB) crossing strategies |
| Q50142281 | Photodynamic therapy in 3D cancer models and the utilisation of nanodelivery systems. |
| Q36268850 | Photothermal therapeutic application of gold nanorods-porphyrin-trastuzumab complexes in HER2-positive breast cancer |
| Q28818470 | Pigmy MicroRNA: surveillance cops in Therapies kingdom |
| Q40054092 | Poly-N-acryloyl-(l-phenylalanine methyl ester) hollow core nanocapsules facilitate sustained delivery of immunomodulatory drugs and exhibit adjuvant properties. |
| Q30390899 | Safety and efficacy of quadrapeutics versus chemoradiation in head and neck carcinoma xenograft model |
| Q64892507 | True hypopharyngeal carcinosarcoma: a case report and literature review. |
Search more.